• Sulfo-NHS-LC-Biotin: Technical Guide for Surface Protein Lab

  2026-07-30

  Sulfo-NHS-LC-Biotin (sulfosuccinimidyl-6-(biotinamido) hexanoate) enables selective, irreversible biotin labeling of cell surface proteins in aqueous environments. It addresses the need for efficient, membrane-impermeable labeling for applications such as protein detection and purification. This reagent should not be used for intracellular or reversible biotinylation workflows.

• Liproxstatin-1: Precision Ferroptosis Inhibitor for Cell Dea

  2026-07-29

  Liproxstatin-1 empowers researchers to dissect ferroptosis with nanomolar potency and high specificity, protecting cells without interfering with apoptosis or oxidative stress pathways. This guide delivers experimentally validated workflows, troubleshooting strategies, and unique insights for maximizing reproducibility in ferroptosis research.

• Sulfo-NHS-LC-Biotin: Technical Guide for Surface Biotinylati

  2026-07-29

  Sulfo-NHS-LC-Biotin is a water-soluble, membrane-impermeable reagent for covalent biotinylation of primary amines on proteins, particularly on cell surfaces. It enables stable, irreversible labeling in aqueous environments, but is unsuitable for reversible or intracellular protein labeling workflows.

• TGEV Inhibits NHE3 Trafficking via SGLT1-p38 MAPK/AKt2 Pathw

  2026-07-28

  This study reveals that transmissible gastroenteritis virus (TGEV) impairs sodium absorption in pig intestinal epithelial cells by disrupting NHE3 surface trafficking through an SGLT1-mediated p38 MAPK/AKt2 signaling axis. These insights clarify the molecular mechanism of TGEV-induced diarrhea and suggest new targets for intervention in viral enteropathies.

• Sulfo-NHS-LC-Biotin: Practical Guide for Cell Surface Biotin

  2026-07-28

  Sulfo-NHS-LC-Biotin is a water-soluble biotinylation reagent optimized for covalent labeling of primary amines on cell surface proteins, enabling stable downstream capture and detection with biotin-avidin systems. It is not suitable for intracellular or reversible biotinylation workflows due to its membrane-impermeable and irreversible chemistry.

• MCC950 Sodium in Inflammatory Disease Research Workflows

  2026-07-27

  MCC950 sodium (CRID3 sodium salt) empowers researchers with unmatched selectivity for dissecting NLRP3-driven inflammation in both in vitro and in vivo models. This guide translates the latest endothelial cell research and protocol optimizations into actionable strategies for robust, reproducible inflammatory disease investigations.

• Spatiotemporal mRNA Delivery via LNP-Stabilized Emulsions En

  2026-07-27

  Zhou et al. present a lipid nanoparticle-stabilized emulsion system (LSE) that enables precise spatiotemporal control of mRNA delivery, focusing antigen expression in antigen-presenting cells and greatly enhancing T cell responses in vivo. This approach addresses longstanding barriers in mRNA vaccine efficacy by reducing off-target expression and T cell exhaustion.

• Marein Reverses Cancer Drug Resistance via ABCG2 Inhibition

  2026-07-26

  A recent study identifies marein, a flavonoid from Coreopsis tinctoria, as a potent and selective competitive inhibitor of the ABCG2 transporter. By blocking ABCG2-mediated drug efflux, marein restores chemosensitivity in multidrug-resistant cancer cells, offering new insights and tools for addressing transporter-driven chemotherapy resistance.

• DMXAA (Vadimezan): Advanced Workflows in Cancer Biology Rese

  2026-07-25

  DMXAA (Vadimezan) redefines cancer biology workflows by targeting tumor vasculature and amplifying innate immunity through STING pathway activation. This guide delivers stepwise protocols, troubleshooting insights, and practical integration of recent breakthroughs for researchers seeking precision and reproducibility.

• CTP Solution (100 mM): Precision Nucleotide for mRNA Synthes

  2026-07-24

  Explore how CTP Solution (100 mM) empowers advanced RNA synthesis workflows as a substrate for in vitro transcription and mRNA-LNP applications. This article offers a scientific deep-dive into mechanism, assay impact, and translational potential.

• SR-202 (PPAR antagonist): Reliable Tool for Immunometabolic

  2026-07-24

  This article guides biomedical researchers through common experimental challenges in obesity and type 2 diabetes research, focusing on how SR-202 (PPAR antagonist), SKU B6929, enhances reproducibility and mechanistic clarity. With scenario-driven Q&A blocks and evidence-based protocols, scientists gain practical strategies for leveraging this selective PPARγ antagonist in cell viability, adipogenesis, and macrophage polarization assays.

• BicD and MAP7 Synergistically Activate Drosophila Kinesin-1

  2026-07-23

  This study reveals that the adaptor protein BicD and the microtubule-associated protein MAP7 activate homodimeric Drosophila kinesin-1 through complementary mechanisms. The findings clarify how adaptor and microtubule-associated proteins coordinate to regulate molecular motor activity, advancing our understanding of intracellular transport regulation.

• CB-839 (Telaglenastat) in Cancer Metabolism Research Workflo

  2026-07-23

  CB-839 (Telaglenastat) is a potent, selective inhibitor of glutaminase 1, empowering researchers to dissect glutamine metabolism vulnerabilities in aggressive cancers. This article delivers actionable protocol insights, advanced workflow enhancements, and troubleshooting tips to ensure reproducible, high-impact data in cancer metabolism research using APExBIO's CB-839.

• Intravesical p21 mRNA-LNP Therapy for Localized Bladder Canc

  2026-07-22

  Zeng et al. (2026) present a non-viral, intravesical delivery of p21 mRNA-loaded lipid nanoparticles as a targeted tumor suppressor replacement strategy for bladder cancer. Their comprehensive study demonstrates robust tumor growth inhibition and restoration of p21 function in preclinical models, providing a promising direction for localized mRNA therapies.

• Hydroxychloroquine Sulfate in Autoimmune Disease Research Wo

  2026-07-22

  Hydroxychloroquine Sulfate (SKU B4874) is used to inhibit autophagy and toll-like receptor 7/9 signaling in autoimmune disease research models, particularly systemic lupus erythematosus and rheumatoid arthritis. It is best suited for aqueous-based workflows and is not compatible with protocols requiring organic solvents or long-term solution storage.

704 records 6/47 page Previous Next First page 上5页 678910 下5页 Last page